New Hope as Alzheimer’s Drug Slows Memory Decline in Phase 3 Trial
The pharmaceutical company, Eisai, has reported positive results from its successful phase 3 clinical trial of the Alzheimer’s drug, lecanemab. The results show the drug…
Read more...